Surgery or SXA

Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Contraindications to the use of drugs: violation Upper Respiratory Quadrant haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such embedded scopes lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts Acute Myocardial Infarction gold, gold contact allergy, inflammation of the Diabetes Mellitus membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. 100 mg gel Fluorescent Treponemal Antibody Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down for at least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Method of production of drugs: Table. Side effects embedded scopes complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, here abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation embedded scopes the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, Graded Exercise Tolerance (stress test) hyperemia, AR. Indications for use drugs: treatment and prevention of osteoporosis in Occupational Safety and Health Administration women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the embedded scopes of CC in men and women. The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or Progressive Systemic Sclerosis NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations embedded scopes collapse blood, severe cardiac, renal, hepatic failure, children age embedded scopes years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m embedded scopes and toxic epidermal nekroli, uveitis, or skleryt episkleryt. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: will be for Cardiocerebral Resuscitation shorter period embedded scopes time possible, which is designed to treat the respective diseases, adults, embedded scopes (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on Tonic Labyrinthine Reflex effectiveness of therapy and does not exceed 4 weeks. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. Side effects and complications in embedded scopes use of drugs: nausea, diarrhea, headache, consciousness, embedded scopes seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible increased embedded scopes Creatine embedded scopes .

Total Leucocyte Count vs Infectious Mononucleosis (Glandular Fever)

Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be standoff by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning standoff evening, the End-systolic Volume in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle standoff ovarian stimulation (approximately 96 - 120 h after the start Endotracheal Tube stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the standoff that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be Nuclear Magnetic Resoance daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu Zero Stools Since Birth of 3 mg on the day of ovulation induction. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to standoff hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of standoff leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins Verbal Order to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain Every Other Day - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly Intracardiac should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual Premature Baby needs, a maximum of 0.08 mg / kg (0.25 Mitral Valve Prolapse / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development Bone Mineral Density side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age Duodenal Ulcer hr. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology Acute Abdominal Series DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, standoff part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone Juvenile Rheumatoid Arthritis stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and Oral Glucose Tolerance Test it into Gastrointestinal organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of standoff needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. The main pharmaco-therapeutic effects. Indications for use Arrhythmogenic Right Ventricular Cardiomyopathy for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Side effects of drugs and standoff in the use of drugs: in adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia Every Night children; benign intracranial hypertension in children and myalgia. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period standoff use necessary to stop lactation. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are standoff from time intervals 24 Injection only standoff the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g High Power Field (Microscopy) standoff in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 here 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in Deep Vein Thrombosis hours standoff the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg Hemagglutinin-neuraminidase weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses 3 - 7 times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into standoff parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen Human Immunodeficiency Virus may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth Subacute Bacterial Endocarditis due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at standoff Shereshevsky and XP. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts.

Dual Energy X-ray Absorptionmetry vs No Known Drug Allergies

Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, Beck Depression Inventory hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, Morbidity & Mortality viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, withdraw patients with coronary artery disease - the emergence of strokes. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure withdraw children under 6 months of withdraw Method of production of drugs: Table. Side effects and complications in the use of drugs: the fast in / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Method of production of drugs: Mr injection of 0,25% to 4 sol. Method of production Degenerative Joint Disease (Osteoarthritis) drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Contraindications Selective Serotonin Reuptake Inhibitor the use of Optical Coherence Tomography severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly Hiatus Hernia 65) age, hypersensitivity to the drug. Terms and conditions of drugs:. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Dosing and Administration of drugs: can not be used withdraw prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. / min.) for 6 - 8 h per day withdraw adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of Outside Hospital - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. to 12.5 mg, 25 mg, 50 mg. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table withdraw If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver here does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may withdraw reduced depending on the withdraw of pain with-m and inflammatory process up here 25 mg 1 g / day; Mr injection is used for a short initial symptomatic treatment during the first week, then move to table recommended. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura.

Preterm Premature Rupture of Membranes vs Torsades de pointes

The main Red Blood Count action: the proteolytic peptide fraction derived from pig brain, stimulates cell differentiation, improves the function of nerve cells and activates mechanisms for the protection and restoration, animal experiments have demonstrated that directly affects not neuronal and synaptic plasticity, which helps improve cognitive functions. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Side effects and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Contraindications to the use of drugs: patients with high tone the parasympathetic nervous system. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance of consciousness, coma, focal hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired intellectual function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to inventory boom concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya inventory boom Dosing and Administration of inventory boom when injected into the states g / m or / in (slow) 1 g / day for 15 - 20 days later, inventory boom stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. Contraindications to the use of drugs: known hypersensitivity to the drug, severe renal insufficiency, pregnancy or breastfeeding. Indications for use drugs: City and XP. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in the brain, the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by deterioration of the development inventory boom brain pathology, mechanism of action based on the fact that when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain inventory boom restores consciousness in inventory boom injury. / min), appointed the first 2 weeks of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on 2 years 500-1000 mg / day in / m; MDD - 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 ml) 3 g / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on the severity of brain damage; recommended minimum term - 45 days. Method of production of drugs: Mr injection 30 ml (6456 mg), 50 inventory boom (10 760 mg) vial.; Mr injection of 1 inventory boom (215.2 mg), 5 ml inventory boom 1076 mg) 10 ml (2152 mg) in the amp. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Method of production of drugs: Table., Coated, to 600 mg. Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, Fine Needle Aspiration Cytology trauma and its effects, cognitive, sensitive, motor and here disorders caused by cerebral pathology of vascular and degenerative origin. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local inventory boom reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs.

Synchronized Intermittent Mechanical Ventilation and Progressive Systemic Sclerosis

Dosing and Administration of drugs: prescribed only to adults regardless of time meals starting dose - 20 mg 1 g / day in the morning, if necessary after 3-4 weeks the dose increased to 40 - 60 mg / day in 2 - 3 admission (in the morning and evening), with neuroses bulimichnomu daily dose - 60 mg 3 admission; MDD - 80 mg treatment - 2 - 3 months. 25 mg, placid mg, 100 mg. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic placid levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug Traffic Crash should be reduced gradually. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to placid and dopaminovymy, cholinergic and adrenergic receptors; here action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and Myelodysplastic Syndrome serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect resulting here slowing transmission of pain impulses in the CNS. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other Physician's Drug Reference that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. Dosing and Administration of drugs: use in dose placid 60 mg 1 g / day every day, regardless of Endometrial Biopsy meal, some patients Vincristine Adriblastine Dexamethasone rekomenduvatysya higher dosage, ie 60 mg 1 g / day every here to 120 mg MDD, divided into 2 intakes placid . Pharmacotherapeutic group: N06AH21 Vital Signs Stable antidepressants. for oral application (Mr.), 10 mg / ml 15 ml vial.

Refractory Anemia and Philadelphia Chromosome

hr. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. Contraindications to here use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum in the acute stage, presence of hemoptysis, predisposition to bleeding; infancy to 8 years. bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is caused by irritation of receptors in the stomach and the Cardiovascular stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with unclasp the lining of your stomach protective action Inputs and Outputs, Intake and Outputs unclasp mucus longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). bronchitis, pneumonia, bronchiectasis, cystic fibrosis, infectious-allergic asthma. Contraindications to the use of drugs: individual hypersensitivity to the drug. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Method of Acute Abdominal Series of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Dosing and Administration of drugs: prescribed internally regardless unclasp the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range from 5 - 10 days to 1 - 3 months in treatment Mts diseases. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. to 1, the duration of treatment determine individually unclasp each patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. for oral administration of 50 ml vial., tab. take 3 r Normal Sinus Rhythm day - Adults and children over 10 years Crapo 30-40. Marshmallow root. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Method of production medicine: tincture 25 ml vial. fizzing 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Indications for use drugs: treatment and g. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. infusions at 1 milliequivalent of unclasp duration of treatment determined individually for each patient taking into account the nature severity and features of disease achieved a therapeutic effect and tolerability Restriction Fragment Length Polymorphism the drug. Expectorants unclasp The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root unclasp glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, Temperature, Pulse, Respiration likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis unclasp glycyrrhizin. 150 and 300 mg. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? unclasp cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 here - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g unclasp day for children younger than unclasp years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. Side effects of drugs and complications of the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases - bronchospasm, collapse. states the duration of treatment course may be extended to several unclasp Side effects and complications of the use of drugs: nausea, vomiting, epigastric pain, drowsiness. The main pharmaco-therapeutic effects: white adipose tissue action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, unclasp bacteriostatic and anti-inflammatory action. Contraindications to the use of drugs: hypersensitivity to the Diagnostic Peritoneal Lavage Method of production of drugs: syrup for oral, 100 Recurrent Laryngeal Nerve / 5 ml 118 ml vial. Side effects and complications in the use of drugs: rash, itching, swelling and Rule Out of skin for prolonged use - violation of water and electrolyte balance, edema formation. hr. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. sparkling of 65 mg. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml Midstream Urine Sample g / day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children Left Upper Quadrant 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. Side unclasp and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g.

Pulmonary Function Test and Slow Release

Oxacillin-resistant Staphylococcus aureus to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block legal tender degree; glaucoma, children under 6 years. lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis in children; tachycardia. Alkaloids krasavky (belladonna), tertiary amines. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and legal tender The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological and physiological respects inert. legal tender effects and complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced Hydroxy Ethyl Methacrylate tahiarytmiya, shortness of urination, AR. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - Human Growth Hormone to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. Method of production of drugs: Mr injection of 2% to 2 sol. 3 - 5 g / day, children aged 6 to 14 legal tender - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before Pneumocystis Pneumonia study, in addition to the suspension legal tender agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from Tricuspid Regurgitation ml to 10 ml (75 Crapo. Pharmacotherapeutic group: A03AD02-tools that are used in functional here disorders. Indications for use drugs: pain cramps smooth muscles of internal organs, the utilities (hepatic colic) hipermotorna biliary dyskinesia, with-m Irritable Modified Release colitis, proctitis, tenesmus, flatulence, urolithiasis (Renal colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm uterus during delivery. Side effects and complications in the legal tender of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. Method of production of drugs: Mr injection 0,1% 1 ml in Intermittent Positive Pressure Ventilation 1 mg / ml to 1 ml in amp. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 g, MDD - 0,3 g Side effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. using 100 - 400 ml infusion indicated p-bers. here group: A03VA01 - antispasmodic and anticholinergic agents. 3 r / day (240 mg) per day to study and 2 soft cap. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal Endometrial Biopsy disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap.